comparemela.com
Latest Breaking News On - Vx 880 - Page 1 : comparemela.com
VX-880 Shows Promise for Insulin, Glucose Management in T1D in New Data
New findings show that VX-880, a stem cell-derived islet cell therapy, can restore endogenous insulin secretion and improve glycemic control in people living with type 1 diabetes (T1D).
Netherlands
Switzerland
United-states
Toronto
Ontario
Canada
Norway
American
Trevorw-reichman
American-diabetes-association
Ajmera-transplant-center
Vertex trial for hypoglycaemia therapy shows early promise
New data now reveals significant increases in the blood glucose time-in-range compared to baseline, following VX-880 dosage - News - PharmaTimes
Camillo-ricordi
Bastiano-sanna
Vertex-pharmaceuticals
Vertex
Hypoglycaemia
Vx-880
vimarsana © 2020. All Rights Reserved.